- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02335801
The TOSCA Registry: Hormonal and Metabolic Deficiencies in Chronic Heart Failure (TOSCA)
The TOSCA Registry: Epidemiology, Clinical and Prognostic Value of Hormonal and Metabolic Deficiencies in Chronic Heart Failure
Aperçu de l'étude
Statut
Les conditions
Description détaillée
Despite the effectiveness of the neurohormonal model to explain the progression of heart failure and the many insights that it provided for the development of new therapies, there is increasing clinical evidence that suggests that our current models fail to completely explain the disease progression. Thus, neurohormonal models may be necessary but not sufficient to explain all aspects of disease progression in the failing heart. There is evidence suggesting that in heart failure there is a metabolic imbalance characterized by the predominance of the catabolic status over the anabolic drive.
Aim of this registry is to determine the prevalence of hormone/metabolic deficiencies in heart failure patients and to look for possible association with clinical variables. Moreover, enrolled patients will be followed up for a mean of 2,5 years in order to collect outcome data including all-cause mortality, cardiovascular mortality, hospitalizations.
This is a multi-center observational study involving several Italian Department of Cardiology, Endocrinology, Internal Medicine
Type d'étude
Inscription (Anticipé)
Contacts et emplacements
Lieux d'étude
-
-
-
Bari, Italie
- Recrutement
- Policlinico di Bari
-
Contact:
- Massimo Iacoviello, MD
- E-mail: massimo.iacoviello@cardio.uniba.it
-
Contact:
- Vincenzo Triggiani, MD
- E-mail: v.triggiani@endo.uniba.it
-
Catania, Italie
- Recrutement
- Policlinico "Vittorio Emanuele" University of Catania
-
Contact:
- Ines Monte, MD
- E-mail: inemonte@unict.it
-
Catanzaro, Italie
- Recrutement
- Unità Operativa di Malattie Cardiovascolari del Policlinico Mater Domini
-
Contact:
- Francesco Perticone
- E-mail: perticone@unicz.it
-
Contact:
- Antonio Belfiore
- E-mail: belfiore@unicz.it
-
Enna, Italie
- Recrutement
- UOC di Medicina Interna IRCCS Oasi Maria SS
-
Contact:
- Letizia Ragusa, MD
- E-mail: lragusa@oasi.en.it
-
Ferrara, Italie
- Recrutement
- UOC Clinica Medica Dipartimento ad Attività Integrata di Medicina Azienda Ospedaliera-Universitaria S.Anna
-
Contact:
- Roberto Manfredini, MD
- E-mail: roberto.manfredini@unife.it
-
Florence, Italie
- Pas encore de recrutement
- University of Florence
-
Contact:
- Pietro Amedeo Modesti, MD
- E-mail: pamodesti@unifi.it
-
Milan, Italie
- Recrutement
- IRCCS Policlinico San Donato Milanese
-
Contact:
- Michele Arcopinto, MD
- E-mail: michele.arcopinto83@gmail.com
-
Naples, Italie, 80100
- Recrutement
- Department of Traslational Sciences - Federico II University
-
Contact:
- Antonio Cittadini, MD
- Numéro de téléphone: +39 081 7464375
- E-mail: antonio.cittadini@unina.it
-
Contact:
- Michele Arcopinto, MD
- Numéro de téléphone: +39 339 7707531
- E-mail: michele.arcopinto83@gmail.com
-
Napoli, Italie
- Recrutement
- AORN V. Monaldi SUN - Centro di diagnosi e cura Cardiomiopatie e Scompenso Cardiaco
-
Contact:
- Giuseppe Limongelli, MD
- E-mail: limongelligiuseppe@libero.it
-
Napoli, Italie
- Recrutement
- Dipartimento di Scienze Biomediche Avanzate Università degli studi di Napoli Federico II
-
Contact:
- Pasquale Perrone-Filardi, MD
- E-mail: pasquale.perronefilardi@unina.it
-
Palermo, Italie
- Pas encore de recrutement
- U.O.S. Endocrinologia Ospedali Riuniti "Villa Sofia - Cervello"
-
Contact:
- Graziella Malizia, MD
- E-mail: graziella.malizia@alice.it
-
Contact:
- Piernicola Garofalo, MD
- E-mail: piernicolagarofalo@alice.it
-
Rome, Italie
- Recrutement
- U.O. di Riabilitazione Cardiologica IRCCS S. Raffaele Pisana
-
Contact:
- Maurizio Volterrani, MD
- E-mail: maurizio.volterrani@sanraffaele.it
-
Rome, Italie
- Recrutement
- UOC Endocrinologia e Malattie del Metabolismo Policlinico Universitario Gemelli
-
Contact:
- Antonio Mancini, MD
- E-mail: mancini.giac@mclink.it
-
Salerno, Italie
- Recrutement
- U.O. di Cardiologia e UTIC Ospedale S. Maria Incoronata dell'Olmo
-
Contact:
- Eduardo Bossone, MD, PhD
- E-mail: ebossone@hotmail.com
-
Contact:
- Francesco Ferrara, MD
- E-mail: francesco.ferrara30@tin.it
-
Verona, Italie
- Recrutement
- Medicina Generale ad Indirizzo Endocrinologico - d.O. Azienda Ospedaliera Universitaria Integrata
-
Contact:
- Roberto Castello, MD
- E-mail: roberto.castello@ospedaleuniverona.it
-
-
Bari
-
Cassano delle Murge, Bari, Italie
- Recrutement
- U.O. di Cardiologia 2 IRCCS-Istituto Scientifico di Riabilitazione di Cassano delle Murge
-
Contact:
- Andrea Passantino, MD
- E-mail: andrea.passantino@fsm.it
-
-
Napoli
-
Nola, Napoli, Italie
- Recrutement
- Santa Maria della Pietà Hospital
-
Contact:
- Luigi Caliendo, MD
- E-mail: l.caliendo@alice.it
-
Contact:
- Luciano Carbone, MD
- E-mail: luciano_carbone@virgilio.it
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- patients of either sex affected by CHF, secondary to ischemic or idiopathic dilated cardiomyopathy
- left ventricle ejection fraction 40% or less
Exclusion Criteria:
- severe liver disease
- serum creatinine levels >2.5 mg/dl
- history of active cancer with life expectancy below 1 year
- acute coronary syndrome in the previous 6 months
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
all-cause mortality and hospitalization
Délai: every six months (up to 5 years)
|
outcome assessed during scheduled visits or phone calls
|
every six months (up to 5 years)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
cardiovascular mortality
Délai: every six months (up to 5 years)
|
outcome assessed during scheduled visits or phone calls
|
every six months (up to 5 years)
|
cardiovascular hospitalizations
Délai: every six months (up to 5 years)
|
outcome assessed during scheduled visits or phone calls
|
every six months (up to 5 years)
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
---|---|---|
reduction in peak oxygen consumption
Délai: every six months (up to 5 years)
|
outcome assessed during scheduled visits
|
every six months (up to 5 years)
|
left ventricular volumes
Délai: every six months (up to 5 years)
|
outcome assessed during scheduled visits
|
every six months (up to 5 years)
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Antonio Cittadini, Federico II University
Publications et liens utiles
Publications générales
- Cittadini A, Saldamarco L, Marra AM, Arcopinto M, Carlomagno G, Imbriaco M, Del Forno D, Vigorito C, Merola B, Oliviero U, Fazio S, Sacca L. Growth hormone deficiency in patients with chronic heart failure and beneficial effects of its correction. J Clin Endocrinol Metab. 2009 Sep;94(9):3329-36. doi: 10.1210/jc.2009-0533. Epub 2009 Jul 7.
- Bossone E, Limongelli G, Malizia G, Ferrara F, Vriz O, Citro R, Marra AM, Arcopinto M, Bobbio E, Sirico D, Caliendo L, Ballotta A, D'Andrea A, Frigiola A, Isgaard J, Sacca L, Antonio C; T.O.S.CA. Investigators. The T.O.S.CA. Project: research, education and care. Monaldi Arch Chest Dis. 2011 Dec;76(4):198-203. doi: 10.4081/monaldi.2011.177.
- Arcopinto M, Isgaard J, Marra AM, Formisano P, Bossone E, Vriz O, Vigorito C, Sacca L, Douglas PS, Cittadini A. IGF-1 predicts survival in chronic heart failure. Insights from the T.O.S.CA. (Trattamento Ormonale Nello Scompenso CArdiaco) registry. Int J Cardiol. 2014 Oct 20;176(3):1006-8. doi: 10.1016/j.ijcard.2014.07.003. Epub 2014 Jul 11. No abstract available.
- Cittadini A, Marra AM, Arcopinto M, Bobbio E, Salzano A, Sirico D, Napoli R, Colao A, Longobardi S, Baliga RR, Bossone E, Sacca L. Growth hormone replacement delays the progression of chronic heart failure combined with growth hormone deficiency: an extension of a randomized controlled single-blind study. JACC Heart Fail. 2013 Aug;1(4):325-330. doi: 10.1016/j.jchf.2013.04.003. Epub 2013 Aug 5.
- Salzano A, D'Assante R, Iacoviello M, Triggiani V, Rengo G, Cacciatore F, Maiello C, Limongelli G, Masarone D, Sciacqua A, Filardi PP, Mancini A, Volterrani M, Vriz O, Castello R, Passantino A, Campo M, Modesti PA, De Giorgi A, Arcopinto M, Gargiulo P, Perticone M, Colao A, Milano S, Garavaglia A, Napoli R, Suzuki T, Bossone E, Marra AM, Cittadini A; T.O.S.CA. Investigators. Progressive right ventricular dysfunction and exercise impairment in patients with heart failure and diabetes mellitus: insights from the T.O.S.CA. Registry. Cardiovasc Diabetol. 2022 Jun 16;21(1):108. doi: 10.1186/s12933-022-01543-3.
- Cittadini A, Salzano A, Iacoviello M, Triggiani V, Rengo G, Cacciatore F, Maiello C, Limongelli G, Masarone D, Perticone F, Cimellaro A, Perrone Filardi P, Paolillo S, Mancini A, Volterrani M, Vriz O, Castello R, Passantino A, Campo M, Modesti PA, De Giorgi A, Monte IP, Puzzo A, Ballotta A, D'Assante R, Arcopinto M, Gargiulo P, Sciacqua A, Bruzzese D, Colao A, Napoli R, Suzuki T, Eagle KA, Ventura HO, Marra AM, Bossone E; T.O.S.CA. Investigators. Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry. Eur J Prev Cardiol. 2021 Dec 29;28(15):1691-1700. doi: 10.1093/eurjpc/zwab020.
- Bossone E, Arcopinto M, Iacoviello M, Triggiani V, Cacciatore F, Maiello C, Limongelli G, Masarone D, Perticone F, Sciacqua A, Perrone-Filardi P, Mancini A, Volterrani M, Vriz O, Castello R, Passantino A, Campo M, Modesti PA, De Giorgi A, Monte I, Puzzo A, Ballotta A, Caliendo L, D'Assante R, Marra AM, Salzano A, Suzuki T, Cittadini A; TOSCA Investigators. Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: rationale, design, and demographic characteristics of the T.O.S.CA. Registry. Intern Emerg Med. 2018 Aug;13(5):661-671. doi: 10.1007/s11739-018-1844-8. Epub 2018 Apr 4.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- TOSCA0001
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Insuffisance cardiaque chronique
-
Region SkaneInscription sur invitationInsuffisance cardiaque New York Heart Association (NYHA) Classe II | Insuffisance cardiaque Classe III de la New York Heart Association (NYHA)Suède
-
Medical University of BialystokInstitute of Cardiology, Warsaw, Poland; Medical University of Lodz; Poznan... et autres collaborateursPas encore de recrutementInsuffisance cardiaque, systolique | Insuffisance cardiaque avec fraction d'éjection réduite | Insuffisance cardiaque New York Heart Association Classe IV | Insuffisance cardiaque Classe III de la New York Heart AssociationPologne
-
University of WashingtonAmerican Heart AssociationComplétéInsuffisance cardiaque, congestive | Altération mitochondriale | Insuffisance cardiaque New York Heart Association Classe IVÉtats-Unis
-
PfizerComplétéLeucémie, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) PositifFrance, États-Unis, Canada, Espagne, Tchéquie, Singapour, Thaïlande, Danemark, Norvège, Corée, République de, Finlande, Hongrie, Suède, Pays-Bas, Italie, Allemagne, Ukraine, Afrique du Sud, Taïwan, Australie, Belgique, Israël, Mexique, Pologn... et plus